MatthewFletcherMD

PubMed

• 2 citations
  Very Late Relapse in Pediatric Acute Myeloid Leukemia: A Case Report and Brief Literature Review.
  Nathan VanderVeen, Matthew Fletcher, Robert Vasquez, Graham D Unis> ;Journal of Pediatric Hematology/oncology. 2021 Aug 1
• ITP Is Neither Idiopathic nor Always Benign.
  Meghan Konda, Matthew Fletcher, Rajasekharan Warrier> ;Clinical Pediatrics. 2021 Mar 1
• Is This Working "Well" for Pediatrics? The Diagnosis and Treatment of Thromboembolic Disease in a Patient With Protein C Deficiency.
  Rebecca Samuel, Angelina Dixon, Paige K. Kretschmar, Matthew Fletcher, Rajasekharan Warrier> ;Clinical Pediatrics. 2020 Jan 1
• 1 citations
  Fever and Leg Pain: Consider ALL the Diagnoses
  Lesley N. Desmond, Matthew Fletcher, Rajasekharan Warrier> ;Ochsner Journal. 2019 Jun 20
• 1 citations
  Sports Injury or Venous Thrombosis
  Heather Alva, Nicholas Goyeneche, Matthew Fletcher, Raj Warrier> ;Clinical Pediatrics. 2019 May 29
• 1 citations
  Procalcitonin to Identify Neoplastic Inflammation.
  Anne Fenton, Paige K. Kretschmar, Russel W. Steele, Matthew Fletcher, Rajasekharan Warrier> ;Clinical Pediatrics. 2019 Apr 17
• 1 citations
  Fever and Bone Pain Is Not Always Osteomyelitis.
  Lahiru Ranasinghe, Matthew Fletcher, Rajasekharan Warrier> ;Clinical Pediatrics. 2018 Aug 1
• 179 citations
  l-Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
  Matthew Fletcher, Maria E. Ramirez, Rosa A. Sierra, Patrick Raber, Paul Thevenot, Amir A. Al-Khami, Dulfary Sanchez-Pino, Claudia Hernandez, Dorota Wyczechowska, Augus...> ;Cancer Research. 2015 Jan 15
• 199 citations
  Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways
  Patrick Raber, Paul Thevenot, Rosa A. Sierra, Dorota Wyczechowska, Daniel Halle, Maria E. Ramirez, Augusto C. Ochoa, Matthew Fletcher, Cruz Velasco, Anna Wilk, Krzyszt...> ;International Journal of Cancer. 2014 Jun 15
• 5 citations
  Successful treatment of acquired hemophilia a with rituximab and steroids in a 5-year-old girl.
  Matthew Fletcher, Ofelia Crombet, Jaime Morales-Arias> ;Journal of Pediatric Hematology/oncology. 2014 Mar 1
• 77 citations
  Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer.
  Matthew Fletcher, Hailey Hodgkiss, Song Zhang, Rachel Browning, Colleen Hadden, Tanja Hoffman, Naomi J. Winick, Timothy L. McCavit> ;Pediatric Blood & Cancer. 2013 Aug 1
• 99 citations
  Specific Assembly with the NMDA Receptor 3B Subunit Controls Surface Expression and Calcium Permeability of NMDA Receptors
  Keiko Matsuda, Matthew Fletcher, Yoshinori Kamiya, Michisuke Yuzaki> ;The Journal of Neuroscience. 2003 Nov 5
• Join now to see all

Journal Articles

• Subpopulations of Myeloid-Derived Suppressor Cells (MDSC) impair T cell responses through independent nitric oxide-related pathways  
  Raber, P., Thevenot, P., Sierra, R., Wyczechowska, D., Halle, D., Ramirez, M., Ochoa, A., Fletcher, M., Velasco, C., Wilk, A., Reiss, K., Rodriguez, P., International Journal of Cancer, 1/15/2014
• Successful treatment of acquired hemophilia A with rituximab and steroids in a 5 year-old girl  
  Fletcher, M., Velez, M., Morales, J., Journal of Pediatric Hematology and Oncology, 1/1/2014
• Successful treatment of acquired hemophilia A with rituximab in a 5 year-old girl with intestinal perforation secondary to small bowel obstruction  
  Fletcher, M., Velez, M., Morales, J., Pediatric Blood and Cancer, 1/1/2012
• Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer  
  Fletcher, M., Hodgkiss, H., Zhang, S., Browning, R., Hadden, C., Hoffman, T., Winick, N., McCavit, T., Pediatric Blood and Cancer, 1/1/2012
• Does time-to-antibiotics predict outcome of febrile neutropenia in pediatric cancer?  
  Fletcher, M, Hodgkiss, H., Browning, R., Hoffman, T., Hadden, C., Winick N. and McCavit, T., Journal of Clinical Oncology, 1/1/2011
• Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors  
  Matsuda, K., Fletcher, M., Kamiya, Y., Yuzaki, M., Journal of Neuroscience, 1/1/2003
• Join now to see all

Abstracts/Posters

• Allogeneic Stem Cell Transplantation Using Reduced Intensity Conditioning: A Case Series.
  Fletcher, M., Wall, L., Paris, K., Yu, L., Pediatric Blood and Marrow Transplant Consortium/American Society of Pediatric Hematology and Oncology Tandem Annual Meeting, Chicago, IL, 1/1/2014
• Modulation of T-cell responses through L-arginine metabolism: A new therapy from an old enemy.
  Fletcher, M., Ramirez, M., Sierra, R., Raber, P., Thevenot, P., Rodriguez, P., LSU Pediatrics Research Day, New Orleans, LA, 1/1/2014
• "Allogeneic Stem Cell Transplantation Using Reduced Intensity Conditioning: A Case Series."
  Fletcher, M., Wall, L., Paris, K., Yu, L., LSU Pediatrics Research Day, New Orleans, LA, 1/1/2014
• A 10-year retrospective study of lymphoma in the monoclonal antibodies era.
  Fletcher, M., Jones, M., Velasco-Gonzales, C., Velez, M., American Federation for Medical Research Southern Regional Meeting, New Orleans, LA, 1/1/2013
• The role of levofloxacin prophylaxis for BK virus in pediatric hematopoietic stem cell transplant.
  Fletcher, M., Harry, J., Velasco-Gonzales, C., Yu, L., American Federation for Medical Research Southern Regional Meeting, New Orleans, LA, 1/1/2013
• "The role of levofloxacin prophylaxis for BK virus in pediatric hematopoietic stem cell transplant."
  Fletcher, M., Harry, J., Velasco-Gonzales, C., Yu, L., American Society for Pediatric Hematology and Oncology/Pediatric Bone Marrow Transplant Consortium Tandem Annual Meeting, Miami, FL, 1/1/2013
• "Successful allogeneic stem cell transplantation in X-linked lymphoproliferative disease using reduced intensity conditioning"
  Fletcher, M., Paris, K., Yu, L., Primary Immunodeficiency Treatment Consortium Scientific Workshop, Houston, TX, 1/1/2013
• A 10-year retrospective study of lymphoma in the monoclonal antibodies era.
  Fletcher, M., Jones, M., Velasco-Gonzales, C., Velez, M., Children's Hospital of New Orleans Pediatric Research Day, New Orleans, LA, 1/1/2013
• "Implementation of a home chemotherapy log in a pediatric oncology clinic."
  Fletcher, M., Louisiana State University Health Sciences Center EQuIP Quality Improvement and Patient Safety Forum, New Orleans, LA, 1/1/2013
• "Modulation of T-cell responses through L-arginine metabolism: A new therapy from an old enemy."
  Fletcher, M., Ramirez, M., Sierra, R., Raber, P., Thevenot, P., Rodriguez, P., American Society of Hematology Annual Meeting, New Orleans, LA, 1/1/2013
• "Successful treatment of acquired hemophilia A with rituximab in a 5 year-old girl with intestinal perforation secondary to small bowel obstruction."
  Fletcher, M., Velez, M., Morales, J., American Society for Pediatric Hematology and Oncology Annual Meeting, New Orleans, LA, 1/1/2012
• Does time-to-antibiotics predict outcome of febrile neutropenia in pediatric cancer?
  Fletcher, M, Hodgkiss, H., Browning, R., Hoffman, T., Hadden, C., Winick N. and McCavit, T., American Society for Pediatric Hematology and Oncology Annual Meeting, New Orleans, LA, 1/1/2012
• Does time-to-antibiotics predict outcome of febrile neutropenia in pediatric cancer?
  Fletcher, M, Hodgkiss, H., Browning, R., Hoffman, T., Hadden, C., Winick, N. and McCavit, T., American Society for Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2011
• "NMDA receptor exhibits decreased Ca2+ permeability and desensitization following incorporation of NR4 receptor subunit"
  Fletcher, M., Matsuda, K., Yuzaki, M., Rhodes College Undergraduate Research and Creative Activity Symposium, Memphis, TN, 1/1/2004
• "Characterization of the NR4 NMDA receptor subunit"
  Fletcher, M., Matsuda, K., Yuzaki, M., St. Jude's Children's Hospital Summer Plus Research Symposium, Memphis, TN, 1/1/2003
• Join now to see all